Dr. Diptesh Gupta, M.D

NPI: 1326201260
Total Payments
$12,582
2024 Payments
$1,346
Companies
48
Transactions
428
Medicare Patients
5,764
Medicare Billing
$894,501

Payment Breakdown by Category

Food & Beverage$11,119 (88.4%)
Travel$1,056 (8.4%)
Education$406.93 (3.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,119 410 88.4%
Travel and Lodging $1,056 3 8.4%
Education $406.93 15 3.2%

Top Paying Companies

Company Total Records Latest Year
Baxter Healthcare $2,217 22 $0 (2023)
AstraZeneca Pharmaceuticals LP $1,832 65 $0 (2024)
Amgen Inc. $1,300 45 $0 (2024)
Bard Peripheral Vascular, Inc. $895.08 18 $0 (2023)
Daiichi Sankyo Inc. $751.14 29 $0 (2023)
Otsuka America Pharmaceutical, Inc. $548.71 29 $0 (2024)
OPKO Pharmaceuticals, LLC $533.27 28 $0 (2024)
Aurinia Pharma U.S., Inc. $451.04 17 $0 (2024)
Vifor Pharma, Inc. $301.61 17 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $299.61 14 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,346 56 Amgen Inc. ($229.95)
2023 $1,778 56 Baxter Healthcare ($287.75)
2022 $1,901 63 Amgen Inc. ($428.66)
2021 $3,024 112 AstraZeneca Pharmaceuticals LP ($514.17)
2020 $1,347 56 AstraZeneca Pharmaceuticals LP ($447.48)
2019 $2,690 59 BAXTER HEALTHCARE ($1,498)
2018 $311.80 15 Medtronic Vascular, Inc. ($53.87)
2017 $185.24 11 Relypsa, Inc. ($70.68)

All Payment Transactions

428 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
12/16/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $16.25 General
Category: Inflammation
11/19/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $23.91 General
Category: Immunology
11/14/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $24.07 General
Category: NEPHROLOGY
11/07/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $22.22 General
Category: DIABETES
11/05/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $22.81 General
Category: LUPUS NEPHRITIS
11/05/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $21.26 General
Category: Inflammation/Rare Disease
11/01/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $23.99 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA
11/01/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $20.12 General
Category: Immunology
10/30/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $23.07 General
Category: Inflammation/Rare Disease
10/29/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $22.37 General
Category: NEPHROLOGY
10/28/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $17.40 General
Category: Inflammation
10/23/2024 CorMedix Inc. DefenCath (Drug) Food and Beverage In-kind items and services $19.40 General
Category: Catheter Lock Solution
10/10/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $21.68 General
Category: Inflammation/Rare Disease
10/09/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $16.00 General
Category: Obesity
10/04/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $18.69 General
Category: LUPUS NEPHRITIS
10/02/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $15.90 General
Category: Cardiovascular and Metabolism
09/30/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $14.38 General
Category: Inflammation
09/26/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $22.98 General
Category: NEPHROLOGY
09/23/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $15.44 General
Category: GASTROENTEROLOGY
09/19/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $29.34 General
Category: Cardio-renal
09/18/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $18.69 General
Category: Nephrology
09/17/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $16.94 General
Category: Inflammation/Rare Disease
09/10/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $31.07 General
Category: Immunology
09/04/2024 CorMedix Inc. DefenCath (Drug) Food and Beverage In-kind items and services $22.07 General
Category: Catheter Lock Solution
08/26/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $18.06 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 22 1,571 3,036 $698,556 $250,953
2022 20 1,286 2,389 $532,112 $185,469
2021 24 1,404 2,751 $635,318 $227,783
2020 20 1,503 2,847 $664,812 $230,296
Total Patients
5,764
Total Services
11,023
Medicare Billing
$894,501
Procedure Codes
86

All Medicare Procedures & Services

86 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 247 622 $129,998 $53,570 41.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 228 579 $133,749 $52,693 39.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 276 817 $131,537 $48,671 37.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 234 250 $112,250 $32,662 29.1%
36558 Insertion of tunneled central venous tube for infusion (5 years or older) Facility 2023 49 51 $31,824 $9,946 31.3%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 11 36 $21,024 $7,916 37.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 55 55 $17,435 $6,592 37.8%
90935 Hemodialysis procedure with physician evaluation Facility 2023 54 108 $16,200 $5,951 36.7%
36906 Removal and/or dissolving of blood clot in hemodialysis circuit and balloon dilation of dialysis segment and placement of stent with review by radiologist Facility 2023 15 16 $18,400 $5,623 30.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 18 37 $10,397 $4,772 45.9%
36902 Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist Facility 2023 22 23 $12,374 $4,174 33.7%
36589 Removal of tunneled central venous tube Facility 2023 33 36 $14,364 $3,477 24.2%
36901 Insertion of needle and/or tube into hemodialysis circuit with review by radiologist Facility 2023 23 28 $10,528 $3,171 30.1%
99497 Advance care planning, first 30 minutes Facility 2023 41 45 $8,505 $2,616 30.8%
36581 Replacement of tunneled central venous tube Facility 2023 17 20 $8,420 $2,467 29.3%
36907 Balloon dilation of dialysis segment with review by radiologist Facility 2023 12 15 $4,935 $1,663 33.7%
90945 Dialysis procedure including 1 evaluation Facility 2023 16 21 $4,431 $1,241 28.0%
99152 Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes Facility 2023 75 106 $2,862 $987.77 34.5%
77001 Fluoroscopic guidance for insertion or removal of central vein access device Facility 2023 61 72 $3,747 $983.35 26.2%
76937 Ultrasonic guidance for blood vessel access Facility 2023 59 70 $2,600 $767.20 29.5%
75820 Review by radiologist of 1 arm or leg vein of 1 arm or leg image Facility 2023 12 14 $1,176 $535.22 45.5%
36005 Injection for x-ray imaging procedure into vein of arm or leg Facility 2023 13 15 $1,800 $474.54 26.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 241 660 $152,460 $51,906 34.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 192 476 $99,484 $41,442 41.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 235 540 $86,940 $29,302 33.7%

About Dr. Diptesh Gupta, M.D

Dr. Diptesh Gupta, M.D is a Nephrology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326201260.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Diptesh Gupta, M.D has received a total of $12,582 in payments from pharmaceutical and medical device companies, with $1,346 received in 2024. These payments were reported across 428 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($11,119).

As a Medicare-enrolled provider, Gupta has provided services to 5,764 Medicare beneficiaries, totaling 11,023 services with total Medicare billing of $894,501. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Tulsa, OK
  • Active Since 07/09/2008
  • Last Updated 02/24/2020
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1326201260

Products in Payments

  • Non-Franchise (NOF) - NonProduct (Biological) $1,391
  • LOKELMA (Drug) $1,173
  • Parsabiv (Drug) $776.95
  • INJECTAFER (Drug) $751.14
  • Veltassa (Drug) $564.18
  • FARXIGA (Drug) $494.03
  • JYNARQUE (Drug) $468.56
  • LUPKYNIS (Drug) $451.04
  • RAYALDEE (Drug) $388.68
  • Renal - PD (Device) $310.77
  • Kerendia (Drug) $299.61
  • RUBY Coil (Device) $274.87
  • KRYSTEXXA (Biological) $229.59
  • TAVNEOS (Drug) $198.55
  • Tavneos (Drug) $192.75
  • Rituxan (Biological) $165.70
  • BENLYSTA (Biological) $161.93
  • Monoferric (Drug) $145.06
  • Rayaldee (Drug) $144.59
  • Renal - PrisMax System (Device) $136.43

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Tulsa